Talphera, Inc. (TLPH)

0.9256 -0.1144 (-11.00%) At close: 04:00PM EDT

Talphera, Inc.

1850 Gateway Drive
Suite 175
San Mateo, CA 94404
United States
650 216 3500
https://talphera.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 15

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Vincent J. Angotti	CEO & Director	1.02M	N/A	1968
Dr. Pamela Pierce Palmer M.D., Ph.D.	Co-Founder & Chief Medical Officer	752.4k	N/A	1963
Mr. Raffi Mark Asadorian	Chief Financial Officer	683.26k	N/A	1969
Mr. Anil N. Dasu	Chief Engineering Officer	478.09k	N/A	1963
Dr. Shakil Aslam M.D.	Chief Development Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Corporate Governance

Talphera, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.